DELRAY BEACH, Florida,
June 10, 2015 /PRNewswire/
-- PositiveID Corporation ("PositiveID" or "Company") (OTCQB:
PSID), a developer of biological detection and diagnostics
solutions, announced today that it has entered a co-marketing
agreement with DirectView Security Systems, Inc. ("DirectView")
(OTC: DIRV), a provider of video surveillance systems including
body worn cameras, to jointly market the companies' products
to homeland security and first responders.
PositiveID develops molecular diagnostic systems, including
Firefly Dx, which is designed to provide real-time, accurate
diagnostic results in a handheld device, thereby leading to
treatment scenarios at the point of need that are not possible with
existing systems, which require lab-based equipment and can take
hours or even days to provide results. Firefly's applications for
first responders include point-of-need, lab-quality detection of
pathogenic organisms and detection of biological agents associated
with weapons of mass destruction.
DirectView provides, among other products and services, body
worn cameras, video storage servers, digital video recorders, and
network video recorders, to address the needs of first
responders.
"We are excited to enter into this co-marketing agreement with
DirectView to include video surveillance solutions and body worn
cameras to our line of first responder products," stated
William J. Caragol, Chairman and CEO
of PositiveID. "Through collaborating with companies like
DirectView we accomplish two important goals: adding synergistic
products and leveraging the sales channels of both companies to
maximize our efforts and achieve better results."
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and
developer of biological detection systems for America's homeland
defense industry as well as rapid biological testing. PositiveID is
focused on the development of microfluidic systems for the
automated preparation of and performance of biological assays in
order to detect biological threats and analyze biological samples.
For more information on PositiveID, please visit
http://www.psidcorp.com, or connect with PositiveID on Twitter,
Facebook or LinkedIn.
About DirectView Holdings, Inc.
DirectView Holdings, Inc., together with its subsidiaries,
provides video surveillance solutions and teleconferencing products
and services to businesses and organizations. The company operates
in two divisions, Security (Video Surveillance) and Video
Conferencing. The Security division offers technologies in
surveillance systems providing onsite and remote video and audio
surveillance, digital video recording, and services. It also sells
and installs surveillance systems; and sells maintenance
agreements. The company sells its products and services in
the United States and
internationally through direct sales force, referrals, and its
Websites. The Video Conferencing division offers teleconferencing
products and services that enable clients to conduct remote
meetings by linking participants in geographically dispersed
locations. It is involved in the sale of conferencing services
based upon usage, the sale and installation of video equipment, and
the sale of maintenance agreements. This division primarily
provides conferencing products and services to numerous
organizations ranging from law firms, banks, high tech companies
and government organizations. For more information visit our
website at www.DirectView.com and connect with us on Twitter,
LinkedIn, Facebook, and Google+.
Statements about PositiveID's future expectations, including
the likelihood that Firefly Dx is designed to provide real-time,
accurate diagnostic results in a handheld device, thereby leading
to treatment scenarios at the point of need that are not possible
with existing systems, which require lab-based equipment and can
take hours or even days to provide results; the likelihood that
through collaborating with companies like DirectView the Company
accomplishes two important goals: adding synergistic products and
leveraging the sales channels of both companies to maximize our
efforts and achieve better results; constitute "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, Section 21E of the Securities Exchange Act of 1934, and as
that term is defined in the Private Litigation Reform Act of 1995.
Such forward-looking statements involve risks and uncertainties and
are subject to change at any time, and PositiveID's actual results
could differ materially from expected results. These risks and
uncertainties include, without limitation, the Company's ability to
target the bio-threat detection and rapid medical testing sectors;
the Company's ability to complete the development of its Firefly Dx
system; as well as other risks. Additional information about these
and other factors that could affect the Company's business is set
forth in the Company's various filings with the Securities and
Exchange Commission, including those set forth in the Company's
10-K filed on March 30, 2015, and
10-Qs filed on May 15, 2015,
November 17, 2014, and August 14, 2014, under the caption "Risk
Factors." The Company undertakes no obligation to update or release
any revisions to these forward-looking statements to reflect events
or circumstances after the date of this statement or to reflect the
occurrence of unanticipated events, except as required by
law.
Contact:
PositiveID Corporation
Allison Tomek
+1-561-805-8044
atomek@positiveidcorp.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/positiveid-and-directview-security-systems-enter-into-co-marketing-agreement-to-jointly-market-products-to-homeland-security-and-first-responders-300096970.html
SOURCE PositiveID Corporation